These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7633947)

  • 1. Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.
    Hoatlin ME; Kozak SL; Spiro C; Kabat D
    J Mol Med (Berl); 1995 Mar; 73(3):113-20. PubMed ID: 7633947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production.
    Kozak SL; Kabat D
    J Virol; 1990 Jul; 64(7):3500-8. PubMed ID: 2352330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes.
    Bestwick RK; Kozak SL; Kabat D
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5404-8. PubMed ID: 2840658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
    Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-frequency cell surface expression of a foreign protein in murine hematopoietic stem cells using a new retroviral vector.
    Tumas DB; Spangrude GJ; Brooks DM; Williams CD; Chesebro B
    Blood; 1996 Jan; 87(2):509-17. PubMed ID: 8555472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
    Jansen M; Bardenheuer W; Sorg UR; Seeber S; Flasshove M; Moritz T
    Eur J Haematol; 2001 Jul; 67(1):2-13. PubMed ID: 11553261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
    Ohnishi N; Itoh K; Itoh Y; Baum C; Higashitsuji H; Yamaguchi K; Tsuji T; Okanoue T; Fujita J
    Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmoviruses: nonviral/viral vectors for gene therapy.
    Noguiez-Hellin P; Meur MR; Salzmann JL; Klatzmann D
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4175-80. PubMed ID: 8633036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer.
    Ban J; First NL; Temin HM
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():1987-93. PubMed ID: 2549178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retroviral vector suitable for ultrasound image-guided gene delivery to mouse brain.
    Jang J; Yoon K; Hwang DW; Lee DS; Kim S
    Gene Ther; 2012 Apr; 19(4):396-403. PubMed ID: 21900964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of helper cells with two host ranges to generate high-titer retroviral vectors.
    Cosset FL; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina RM; Faure C; Nigon VM; Verdier G
    Virology; 1993 Mar; 193(1):385-95. PubMed ID: 8382402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.
    Yee JK; Miyanohara A; LaPorte P; Bouic K; Burns JC; Friedmann T
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9564-8. PubMed ID: 7937806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
    Otto E; Jones-Trower A; Vanin EF; Stambaugh K; Mueller SN; Anderson WF; McGarrity GJ
    Hum Gene Ther; 1994 May; 5(5):567-75. PubMed ID: 8054374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral gene transfer using safe and efficient packaging cell lines.
    Markowitz D; Hesdorffer C; Ward M; Goff S; Bank A
    Ann N Y Acad Sci; 1990; 612():407-14. PubMed ID: 2291567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
    Baum C; Eckert HG; Stocking C; Ostertag W
    Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
    Morgenstern JP; Land H
    Nucleic Acids Res; 1990 Jun; 18(12):3587-96. PubMed ID: 2194165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of retroviral mutation rates using spleen necrosis virus-based vectors and helper cells.
    Dougherty JP; Temin HM
    Biotechnology; 1991; 16():21-33. PubMed ID: 2007191
    [No Abstract]   [Full Text] [Related]  

  • 20. Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses.
    Takeuchi Y; Simpson G; Vile RG; Weiss RA; Collins MK
    Virology; 1992 Feb; 186(2):792-4. PubMed ID: 1733113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.